Overview
Message From The Chairperson
Center Ventures’ vision is to become the leading professional biotech venture capital firm that paving a way for sustainable future. Our group founded as one of the Taiwan leading oral liquid medication manufacturer with business development adjustment overtimes, we have become one of the leading professional biotech venture capital firms with practical experiences and business expertise that offer the most professional biotechnology incubator platform in Asia Pacific. Our investments include Lumosa Therapeutics, BioGend Therapeutics, Medeon Biodesign, Shine-On BioMedical, Ever Supreme Bio Technology (ESBT), Everfortune, Adimmune etc. along with other public listing or unlisted companies with potential growth.
Our group cultivate the domestic market for more than 60 years, upholding the spirit of our group’s long-term sustainability and delivering profitability growth, Central Ventures Group actively work to paves the way for our group to earn customers loyalty, gain investors’ confidence and to cultivate our talents. To act decisively to ensure our long-term competitiveness, our group continue to actively adoption of ESG (Environmental, Social and Governance) initiatives in our operations, industrial value chain and continue to deepen our connection with the society and to respond to environmental protections.
Over the past years, the world has faced numerous economic, social and geopolitical risks, including uncertainties in globalization and free trade and COVID-19 pandemic impact. Addressing ESG challenges, Center Ventures Group has actively adopted ESG initiatives into our corporate DNA by “driving innovative biotechnology” and “laying a solid foundation for sustainability” to pursue areas of “Unmet Medical Need” by develop more effective biotechnology medication and products. By deepen our partnership with stakeholders, our group continues to build sustainable development in our business operations and to strives to boost the development of the global healthcare industry.
Our group vision is to achieve our goal in “helping visionaries of tomorrow better the lives of today” remain unchanged over 60 years of milestones. Our mission target to bring in both resources and experiences in Asia Pacific to help potential biotechnology and healthcare companies tap into the global market.
Our group committed to increase in a focus on sustainability through the lens of ESG, which we have made efforts to integrate ESG actions and plans into our business operations and company strategy. Together with our management, employees, public association, communities, investors, shareholders, supply chain, customers and all relevant all parties we shall work closely to achieve our ESG goal. Center Ventures Group will continue to launch management system indicators with safety equipment to ensure safety of all of our relative parties including employees and supply chain partner. We shall continue to ensure our customers with best quality products with advance production technology and continue to create more values to our shareholders and stakeholders. Our group shall actively implementing our core enterprise value with positive actions that embed our sustainability through “Innovation、Integrity、Professional、Common Good.”
Center Ventures Group is committed to the pursuit of diversity and sustainability in all areas of our business that shall enabling us to support the biotechnology industry to deliver sustainable solutions. Apart from core business expansion and enhancing our core competitiveness, we committed to implementing major sustainability indicators and continue to create unique pristine values to our clients, shareholders, employees, and society. We also anticipate to working closely with our stakeholders to accomplish tasks and welcome any constructive feedbacks and guidance from all stakeholders. Our group shall continue to integrate ESG factors into our core business and create better future and greater impact on the wider community and environment. Our group set to create foundation that establish to a long-term legacy exist in perpetuity that can be handed down from one generation to the next.
ESG Performance
2022
Governance & Economic
Revenues
767
million2022 Revenues NTD767 Million, EPS NTD 0.17,2022 TWSE Corporate Governance Evaluation; top 6-20%.
2022
Environmental
Energy Saving
351,840
kWhEnergy saving 351,840kWh of electricity in 2022.
2022
Social
Charity Donation
3.34
millionHosting 8 seminars in Promoting medicines safety for children and elderly;charity donation of NTD3.34 million.